Published in J Neuropsychiatry Clin Neurosci on January 01, 2000
Behavioral and Environmental Sensing and Intervention (BESI) | NCT03297268
Feru-guard for Behavioral Symptoms in Dementia | NCT03451760
Diagnosis and Monitoring of Disease Progression Using Deep Neuro Signatures (DNS) | NCT05153941
The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord (2009) 5.50
Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res (2009) 3.31
The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology (2012) 3.01
Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology (2013) 2.73
The protocols for the 10/66 dementia research group population-based research programme. BMC Public Health (2007) 2.54
Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging. J Gerontol A Biol Sci Med Sci (2012) 2.48
Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. Arch Gen Psychiatry (2008) 2.39
Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain (2012) 2.29
Clinicopathologic differences among patients with behavioral variant frontotemporal dementia. Neurology (2013) 2.26
Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol (2008) 2.04
Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis Assoc Disord (2012) 2.02
Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dement (2011) 1.81
The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry (2013) 1.80
Nonpharmacologic management of behavioral symptoms in dementia. JAMA (2012) 1.75
How redesigning AD clinical trials might increase study partners' willingness to participate. Neurology (2008) 1.74
Are the available apathy measures reliable and valid? A review of the psychometric evidence. J Psychosom Res (2010) 1.70
Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trial. BMJ (2012) 1.69
The prevalence, correlates and impact of dementia in Cuba. A 10/66 group population-based survey. Neuroepidemiology (2008) 1.68
Quantitative application of the primary progressive aphasia consensus criteria. Neurology (2014) 1.64
The 10/66 Dementia Research Group's fully operationalised DSM-IV dementia computerized diagnostic algorithm, compared with the 10/66 dementia algorithm and a clinician diagnosis: a population validation study. BMC Public Health (2008) 1.60
In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology (2010) 1.58
Polyunsaturated fatty acids and reduced odds of MCI: the Mayo Clinic Study of Aging. J Alzheimers Dis (2010) 1.58
Predicting missing biomarker data in a longitudinal study of Alzheimer disease. Neurology (2012) 1.56
Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement (2011) 1.54
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
Risk and protective factors for cognitive impairment in persons aged 85 years and older. Neurology (2015) 1.48
TDP-43 is a key player in the clinical features associated with Alzheimer's disease. Acta Neuropathol (2014) 1.47
Cognitive rehabiliation for Parkinson's disease demantia: a study protocol for a pilot randomised controlled trial. Trials (2016) 1.42
Neuroanatomical Correlates of Theory of Mind Deficit in Parkinson's Disease: A Multimodal Imaging Study. PLoS One (2015) 1.39
Alzheimer's disease and mild cognitive impairment. Neurol Clin (2007) 1.39
Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice? Alzheimers Res Ther (2010) 1.30
Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis (2014) 1.30
Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology (2009) 1.28
Amyloid imaging of Lewy body-associated disorders. Mov Disord (2010) 1.27
Assessment and management of behavioral and psychological symptoms of dementia. BMJ (2015) 1.27
Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord (2010) 1.24
The epidemiology of dependency among urban-dwelling older people in the Dominican Republic; a cross-sectional survey. BMC Public Health (2008) 1.22
Anxiety in dementia: a critical review. Clin Psychol Rev (2008) 1.21
Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neurobiol Aging (2008) 1.19
Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study. Am J Psychiatry (2014) 1.16
Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia. CMAJ (2008) 1.15
Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment. Dement Geriatr Cogn Disord (2010) 1.15
Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study. PLoS Med (2012) 1.15
Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions. Biol Psychiatry (2012) 1.13
Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatr Psychiatry (2010) 1.13
Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study. Brain (2010) 1.11
Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study. Alzheimer Dis Assoc Disord (2010) 1.09
The Spanish translation and adaptation of the Uniform Data Set of the National Institute on Aging Alzheimer's Disease Centers. Alzheimer Dis Assoc Disord (2009) 1.09
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. Int Psychogeriatr (2010) 1.08
Association of C-reactive protein with mild cognitive impairment. Alzheimers Dement (2009) 1.08
Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum. Dement Geriatr Cogn Disord (2012) 1.07
A European study investigating patterns of transition from home care towards institutional dementia care: the protocol of a RightTimePlaceCare study. BMC Public Health (2012) 1.07
(Cost)-effectiveness of case-management by district nurses among primary informal caregivers of older adults with dementia symptoms and the older adults who receive informal care: design of a randomized controlled trial [ISCRTN83135728]. BMC Public Health (2005) 1.06
Practical clinical tool to monitor dementia symptoms: the HABC-Monitor. Clin Interv Aging (2012) 1.05
Positive effects of language treatment for the logopenic variant of primary progressive aphasia. J Mol Neurosci (2011) 1.05
Cardiac disease associated with increased risk of nonamnestic cognitive impairment: stronger effect on women. JAMA Neurol (2013) 1.04
Capgras syndrome in Dementia with Lewy Bodies. Int Psychogeriatr (2012) 1.03
The relationship between cognitive impairment and diabetes self-management in a population-based community sample of older adults with Type 2 diabetes. J Behav Med (2011) 1.03
Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease. Mov Disord (2010) 1.03
THE QUICK DEMENTIA RATING SYSTEM (QDRS): A RAPID DEMENTIA STAGING TOOL. Alzheimers Dement (Amst) (2015) 1.02
Predictors of employment and lost hours from work in cancer caregivers. Psychooncology (2008) 1.01
Predicting functional decline in behavioural variant frontotemporal dementia. Brain (2011) 1.00
The University of California at Los Angeles Alzheimer's and Dementia Care program for comprehensive, coordinated, patient-centered care: preliminary data. J Am Geriatr Soc (2013) 1.00
The evolution of primary progressive apraxia of speech. Brain (2014) 0.99
Language and behavior domains enhance the value of the clinical dementia rating scale. Alzheimers Dement (2011) 0.99
Strain and its correlates among carers of people with dementia in low-income and middle-income countries. A 10/66 Dementia Research Group population-based survey. Int J Geriatr Psychiatry (2012) 0.98
Evaluation design of a reactivation care program to prevent functional loss in hospitalised elderly: a cohort study including a randomised controlled trial. BMC Geriatr (2011) 0.98
Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment. Arch Neurol (2011) 0.97
Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts. Am J Geriatr Psychiatry (2013) 0.97
Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Am J Geriatr Psychiatry (2014) 0.97
Self-, collateral- and clinician assessment of depression in persons with cognitive impairment. Aging Ment Health (2008) 0.96
Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria. Am J Geriatr Psychiatry (2008) 0.96
Clinicopathologic correlation in PGRN mutations. Neurology (2007) 0.95
Integrated approach to prevent functional decline in hospitalized elderly: the Prevention and Reactivation Care Program (PReCaP). BMC Geriatr (2012) 0.95
Neuropsychiatric symptoms in behavioral variant frontotemporal dementia and primary progressive aphasia. J Geriatr Psychiatry Neurol (2008) 0.95
The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. Brain (2015) 0.94
Psychosis in Alzheimer's disease in the national Alzheimer's disease coordinating center uniform data set: clinical correlates and association with apolipoprotein e. Int J Alzheimers Dis (2011) 0.94
"Noncognitive" symptoms of early Alzheimer disease: a longitudinal analysis. Neurology (2015) 0.93
Caregiver support service needs for patients with mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord (2010) 0.93
Frequency and impact of informant replacement in Alzheimer disease research. Alzheimer Dis Assoc Disord (2015) 0.93
Neuropsychiatric symptom profile differs based on pathology in patients with clinically diagnosed behavioral variant frontotemporal dementia. Dement Geriatr Cogn Disord (2013) 0.92
[Caregiver burden with dementia patients. A validation study of the German language version of the Zarit Burden Interview]. Z Gerontol Geriatr (2010) 0.91
Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). Alzheimers Dement (Amst) (2016) 0.90
Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study. BMC Neurol (2013) 0.89
IMPROVING THE CLINICAL DETECTION OF LEWY BODY DEMENTIA WITH THE LEWY BODY COMPOSITE RISK SCORE. Alzheimers Dement (Amst) (2015) 0.89
Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations. J Neurol (2011) 0.89
CSF biomarkers of Alzheimer disease: "noncognitive" outcomes. Neurology (2013) 0.88
Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum. Am J Geriatr Psychiatry (2013) 0.87
Improving functional disability and cognition in Parkinson disease: randomized controlled trial. Neurology (2014) 0.87
Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement (2014) 0.87
Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials? Alzheimer Dis Assoc Disord (2015) 0.87
Sleep disturbance in dementia with Lewy bodies and Alzheimer's disease: a multicenter analysis. Dement Geriatr Cogn Disord (2011) 0.86
Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's disease. J Alzheimers Dis (2013) 0.86
Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits? Mol Aspects Med (2015) 0.86
Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement (2012) 0.86
Validation of NINDS-CSN neuropsychological battery for vascular cognitive impairment in Chinese stroke patients. BMC Neurol (2015) 0.86
Identifying common impairments in frail and dependent older people: validation of the COPE assessment for non-specialised health workers in low resource primary health care settings. BMC Geriatr (2015) 0.86
Are apathy and depression independently associated with longitudinal trajectories of cortical atrophy in mild cognitive impairment? Am J Geriatr Psychiatry (2013) 0.85
Clinical Features of Alzheimer Disease With and Without Lewy Bodies. JAMA Neurol (2015) 0.85
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology (2006) 12.10
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 7.68
Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 7.51
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Prevalence of Alzheimer's disease and other dementias in rural India: the Indo-US study. Neurology (1998) 3.82
Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 3.74
Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology (2008) 3.54
A functional imaging study of cooperation in two-person reciprocal exchange. Proc Natl Acad Sci U S A (2001) 3.41
Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry (2001) 3.32
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology (2007) 3.26
A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc (2001) 3.20
Incidence of Alzheimer's disease in a rural community in India: the Indo-US study. Neurology (2001) 2.99
The spectrum of behavioral changes in Alzheimer's disease. Neurology (1996) 2.97
Predicting risk of dementia in older adults: The late-life dementia risk index. Neurology (2009) 2.92
Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades. Arch Gen Psychiatry (1999) 2.89
Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex (2001) 2.88
Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology (2000) 2.79
Unlocking the archive--gene expression in paraffin-embedded tissue. J Pathol (2001) 2.76
Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology (1998) 2.70
Subcortical dementia. Review of an emerging concept. Arch Neurol (1984) 2.65
Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I. Neurology (2000) 2.64
Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med (1997) 2.62
Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci (1994) 2.59
Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol (2001) 2.51
Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging (2002) 2.46
Generalized tensor-based morphometry of HIV/AIDS using multivariate statistics on deformation tensors. IEEE Trans Med Imaging (2008) 2.46
Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol (1996) 2.45
Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology (1991) 2.43
Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology (2010) 2.41
Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys (1980) 2.33
Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (1998) 2.28
Apathy is not depression. J Neuropsychiatry Clin Neurosci (1998) 2.24
Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging (1990) 2.14
The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Arch Gen Psychiatry (1999) 2.07
Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1999) 2.07
Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry (2001) 2.04
Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. Arch Neurol (2000) 2.04
Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project. Neurology (2000) 2.03
Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry (2008) 1.99
Subcortical dementia. Neuropsychology, neuropsychiatry, and pathophysiology. Br J Psychiatry (1986) 1.96
The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol (1996) 1.94
The limbic system: an anatomic, phylogenetic, and clinical perspective. J Neuropsychiatry Clin Neurosci (1997) 1.93
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry (2000) 1.93
Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. Br Med J (Clin Res Ed) (1983) 1.91
Visual hallucinations. Clinical occurrence and use in differential diagnosis. West J Med (1987) 1.91
Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc (1998) 1.88
Genome-wide association study of Alzheimer's disease. Transl Psychiatry (2012) 1.88
Initial cash/asset ratio and asset prices: an experimental study. Proc Natl Acad Sci U S A (1998) 1.87
Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset. Neurology (2004) 1.87
Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry (2005) 1.83
Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury. Crit Care Med (2000) 1.82
The temporal variant of frontotemporal dementia. Brain (1997) 1.76
Age, Alzheimer disease, and brain structure. Neurology (2009) 1.75
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis (2010) 1.73
Behavioral disorders and caregivers' reaction in Taiwanese patients with Alzheimer's disease. Int Psychogeriatr (2001) 1.72
Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study. Neurology (2008) 1.71
Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology (2005) 1.70
Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cereb Cortex (1998) 1.70
Diagnosis of dementia: clinicopathologic correlations. Neurology (1989) 1.68
Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry (2006) 1.67
Chronic divalproex sodium use and brain atrophy in Alzheimer disease. Neurology (2011) 1.66
Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am (1998) 1.63
Cerebral correlates of psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2000) 1.62
The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry (2000) 1.61
Linkage analysis of Alzheimer disease with psychosis. Neurology (2002) 1.58
Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades: II. Neurology (2000) 1.57
The nucleotide sequence of Saccharomyces cerevisiae chromosome IX. Nature (1997) 1.56
Utilization of Alzheimer's disease community resources by Asian-Americans in California. Int J Geriatr Psychiatry (2000) 1.56
Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease. Neurology (1996) 1.55
Vascular dementia and dementia of the Alzheimer type. Cognition, ventricular size, and leuko-araiosis. Arch Neurol (1988) 1.54
ASCIA guidelines for prevention of food anaphylactic reactions in schools, preschools and child-care centres. J Paediatr Child Health (2004) 1.53
Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med (1997) 1.52
Powassan virus infection. A report of three human cases of encephalitis. Am J Dis Child (1974) 1.52
Dose conformity of gamma knife radiosurgery and risk factors for complications. Int J Radiat Oncol Biol Phys (2001) 1.52
Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc (1992) 1.51
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51
Malaria imported into the United Kingdom in 1992 and 1993. Commun Dis Rep CDR Rev (1994) 1.51
The insistent call from functional MRI. Neurology (1997) 1.50
Encephalitis lethargica: lessons for contemporary neuropsychiatry. J Neuropsychiatry Clin Neurosci (1995) 1.49
Depression in epilepsy. Significance and phenomenology. Arch Neurol (1986) 1.48
EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease. Neurology (1997) 1.48
Neuropsychiatric disturbances associated with idiopathic calcification of the basal ganglia. Biol Psychiatry (1983) 1.48
Sucrose intake and coronary heart-disease. Lancet (1968) 1.47
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol (1983) 1.47
The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement. Am J Geriatr Psychiatry (2000) 1.46
Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J Neurochem (1993) 1.46
Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. Arch Neurol (1999) 1.45
Race- and sex-specific ECG models for left ventricular mass in older populations. Factors influencing overestimation of left ventricular hypertrophy prevalence by ECG criteria in African-Americans. J Electrocardiol (2000) 1.45